Calcitriol 0.5 mcg Oral Capsule
RxNorm 308868
Concept Hierarchy & Relationship Mapping
RxNorm Concept Unique Identifier (RxCUI) 308868 represents a standardized clinical drug concept used for cross-system interoperability. This concept aggregates multiple Atom IDs (AUIs), which are specific naming variations and synonyms used across pharmaceutical databases to ensure accurate medication mapping for: calcitriol 0.5 mcg Oral Capsule.
The following semantic concepts and normalized strings are associated with this clinical entity:
This clinical crossover tool is designed for healthcare professionals, pharmacists, and data analysts to safely compare substitute products and manage medication interoperability.
SCDPrescribable
Semantic Clinical Drug (SCD):
Calcitriol 0.0005 mg Oral Capsule
(Atom ID: 12339218)
PSNPrescribable
Prescribable Name (PSN):
Calcitriol 0.5 mcg Oral Capsule
(Atom ID: 6368466)
SYPrescribable
Synonym (SY):
Calcitriol 0.5 mcg Oral Capsule
(Atom ID: 2990320)
PTPrescribable
Designated preferred name (PT):
Calcitriol 500 nanogram oral capsule
(Atom ID: 10295349)
FNPrescribable
Full form of descriptor (FN):
Product containing precisely calcitriol 500 nanogram/1 each conventional release oral capsule (clinical drug)
(Atom ID: 10310107)
Patient Education
Calcitriol
Calcitriol is used to treat and prevent low levels of calcium and bone disease in patients whose kidneys or parathyroid glands (glands in the neck that release natural substances to control the amount of calcium in the blood) are not working normally. It is also used to treat secondary hyperparathyroidism (a condition in which the body produces too much parathyroid hormone [PTH; a natural substance needed to control the amount of calcium in the blood]) and metabolic bone disease in people with kidney disease. Calcitriol is in a class of medications called vitamin D analogs. It works by helping the body to use more of the calcium found in foods or supplements and regulating the body's production of parathyroid hormone.
[Learn More]
* Please review the disclaimer below.